AMA policy supports the FDA's science-based approach to special product labeling, recognizing that there currently is no evidence that there are material differences or safety concerns in available bioengineered foods. Recognizing the public’s interest in the safety of bioengineered foods, the new policy also supports mandatory FDA pre-market systemic safety assessments of these foods as a preventive measure to ensure the health of the public. We also urge the FDA to remain alert to new data on the health consequences of bioengineered foods.

AMA board member Patrice Harris, M.D.


You've heard of red wine and white wine but have you ever heard of blue wine? This blue version of wine is given a taste test to see how it compares to the classics.